Ocuphire Pharma
preclinical data oral blocks | Ocuphire Pharma
Company
Deck Type
Deck date
November 2023
Slide
37 of 42
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Investor Presentation
August 2023
preclinical data oral blocks | Ocuphire Pharma
Results
October 2022
preclinical data oral blocks | Ocuphire Pharma
Investor Day
January 2022
preclinical data oral blocks | Ocuphire Pharma
Related slides by other companies
OKYO Pharma
Results
June 2023
validation efficacy in dry eye mouse model | OKYO Pharma
Recursion Pharmaceuticals
Investor Day
January 2023
clinical efficacy found in in mice models led to significant progression free survival further confidence preclinical studies confirming insight | Recursion Pharmaceuticals
Recursion Pharmaceuticals
Investor Day
January 2023
clinical preclinical studies reduces lesion burden and ameliorates vascular defects in genetic mouse models of further confidence confirm insight | Recursion Pharmaceuticals
Arbutus Biopharma
Investor Presentation
August 2023
reduces in mouse model | Arbutus Biopharma
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io